home / stock / sgbi / sgbi quote
Last: | $0.0015 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0015 |
Close: | $0.0015 |
High: | $0.0015 |
Low: | $0.0015 |
Volume: | 200,000 |
Last Trade Date Time: | 01/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0015 | $0.0015 | $0.0015 | $0.0015 | $0.0015 | 200,000 | 01-17-2024 |
$0.0012 | $0.0012 | $0.0012 | $0.0012 | $0.0012 | 74,808 | 01-16-2024 |
$0.0015 | $0.00216 | $0.0015 | $0.0022 | $0.0015 | 400 | 01-15-2024 |
$0.0015 | $0.00216 | $0.0015 | $0.00216 | $0.0015 | 400 | 01-12-2024 |
$0.0012 | $0.0044 | $0.0012 | $0.0044 | $0.0012 | 6,000 | 01-11-2024 |
$0.004 | $0.00309 | $0.004 | $0.004 | $0.0025 | 1,476 | 01-05-2024 |
$0.0029 | $0.0029 | $0.0029 | $0.0029 | $0.0029 | 90,000 | 01-03-2024 |
$0.0029 | $0.0029 | $0.0029 | $0.0029 | $0.0029 | 400 | 12-20-2023 |
$0.0029 | $0.003155 | $0.0029 | $0.003155 | $0.0029 | 3,000 | 12-06-2023 |
$0.0029 | $0.0029 | $0.0029 | $0.0029 | $0.0029 | 100 | 11-27-2023 |
$0.003495 | $0.003495 | $0.003495 | $0.003495 | $0.003495 | 2,000 | 11-24-2023 |
$0.00375 | $0.00374 | $0.00375 | $0.00375 | $0.00374 | 7,250 | 11-20-2023 |
$0.0029 | $0.0029 | $0.0029 | $0.0029 | $0.0029 | 56,000 | 10-31-2023 |
$0.0029 | $0.0029 | $0.0029 | $0.0029 | $0.0029 | 100 | 10-10-2023 |
$0.0028 | $0 | $0.0028 | $0 | $0 | 1 | 09-28-2023 |
$0.0028 | $0.0028 | $0.0028 | $0.0028 | $0.0028 | 124,998 | 09-13-2023 |
$0.0027 | $0.0027 | $0.0027 | $0.0027 | $0.0027 | 1,300 | 08-30-2023 |
$0.0035 | $0.0035 | $0.0035 | $0.0035 | $0.0035 | 11,990 | 08-16-2023 |
$0.0035 | $0.0035 | $0.0035 | $0.0035 | $0.0035 | 100 | 08-10-2023 |
$0.0035 | $0.0038 | $0.0035 | $0.0038 | $0.0035 | 200,000 | 07-13-2023 |
News, Short Squeeze, Breakout and More Instantly...
Sangui Biotech Intl Inc Company Name:
SGBI Stock Symbol:
OTCMKTS Market:
WITTEN / ACCESSWIRE / March 06, 2019 / The European Patent Office has granted a patent for Sangui's proposed technology/treatment (SBT 102) for septic shock patients, effective March, 6, 2019*. The patent follows up on animal studies carried out by the ECCPS (Excellence Cluster Cardio-Pulmon...